Category: Lanx Inc.
Biomet says it's closed the buyout of Lanx Inc. ahead of its Nov. 29 deadline.
Biomet said today that it closed the acquisition of spinal device maker Lanx Inc.
When the deal was announced early last month, Biomet said it would expand its spine offering with Lanx's Timberline and Aspen spinal fusion systems. The deal was originally expected to close by Nov. 29.
Biomet swings to fiscal 1st-quarter black and announces the acquisition of spinal implant maker Lanx Inc. for an undisclosed amount.
Biomet said it's agreed to acquire spinal implant maker Lanx Inc. for an undisclosed amount as it revealed a swing to fiscal 1st-quarter black.
The Warsaw, Ind.-based orthopedics giant said the deal will expand its spine offering with Lanx's Timberline and Aspen spinal fusion systems.
Stryker (NYSE:SYK) CEO Kevin Lobo told an investors conference audience in Las Vegas yesterday that the medical device company is still in the mergers & acquisitions hunt, even after its newsmaking buyouts of China's Trauson Holdings, Israel's Orthovita and Surpass Medical.
A Delaware state court rules that NuVasive can review documents covering current and former employees' contacts with Lanx, which NuVasive accuses of poaching its talent.
NuVasive Inc. (NSDQ:NUVA) can review documents covering Lanx Inc.'s contacts with current and former NUVA employees it alleges were poached by Lanx.
NuVasive's ongoing legal battle with Lanx Inc. over the defection of a slew of its former sales reps continues with a lawsuit filed against 3 former reps in New York.
NuVasive Inc. (NSDQ:NUVA) opened another front in its ongoing war with rival Lanx Inc., accusing 3 former sales reps of defecting to Lanx and taking trade secrets with them.
Lanx Inc. loses its bid to toss a breach-of-contract lawsuit filed against it by competitor NuVasive, alleging that Lanx raided its national sales force.
Medical device company Lanx Inc. lost a bid to have 1 of at least 2 breach-of-contract lawsuits filed against it by competitor NuVasive (NSDQ:NUVA) thrown out.
Following his resignation from the top job at Stryker, Stephen MacMillan also drops his seat on the Texas Instruments board.
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.
, Electromed Inc.
, InVivo Therapeutics Corp.
, Lanx Inc.
, Mayo Clinic
, NDS Surigical
, Pyng Medical
, Small Bone Innovations Inc.
, Texas Instruments
, Analogic Corp.